FINAL L5 - Innovation in Diabetes Weight Loss Drugs

Question 1

Mounjaro properties;

Answer 1

Dual agonist (GLP-1 receptor agonist) (GIP) (Glucose-Dependent Insulinotropic Polypeptide) receptor agonist
-Improved blood sugar control
-Enhanced weight loss
-Cardiovascular benefits
-Reduced risk of hypoglycemia
-Potential pancreatic beta-cell preservation
-appetite suppression and satiety

Question 2

GLP-1 Peptide Sequences

Answer 2

Look at slide

Question 3

Devices - Benefits

Answer 3

-Better health outcomes:
Ease of admin. increases patient compliance
Data can be shared with provider to monitor adherence and disease state
Eliminates need to travel to a clinic for admin (decrease cost)
Alerts can be sent to care-givers during stress conditions
Dose can be tailored for each specific patient (personalized medicine)